April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Fabrication of a Bio-Prosthetic Cornea from Human Keratocytes
Author Affiliations & Notes
  • Ricardo Martins Gouveia
    School of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, United Kingdom
  • Valeria Castelletto
    School of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, United Kingdom
  • Ian W Hamley
    School of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, United Kingdom
  • Che John Connon
    School of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, United Kingdom
  • Footnotes
    Commercial Relationships Ricardo Gouveia, None; Valeria Castelletto, None; Ian Hamley, None; Che Connon, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5140. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ricardo Martins Gouveia, Valeria Castelletto, Ian W Hamley, Che John Connon, Stem Cells and Nanomaterials Group; Fabrication of a Bio-Prosthetic Cornea from Human Keratocytes. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5140.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

We aim to create a bio-prosthetic human cornea using a bottom-up strategy. For this, we developed a smart enzyme-responsive biomaterial template to direct adhesion, proliferation, alignment, and stratification of human corneal stromal keratocytes. Cells thus instructed are expected to produce native-like stromal tissue, with extracellular matrix (ECM) composed of aligned collagen fibrils and appropriate proteoglycan moieties deposited in lamellae.1 But most importantly, the fabricated corneal tissue will be able to enzymatically degrade the template and control its own release.

 
Methods
 

The enzyme-responsive template was made from self-assembling peptide amphiphile (PA) molecules composed of a hexadecyl lipid chain attached to a peptide headgroup containing a metalloprotease (MMP)-responsive sequence followed by the integrin-binding motif Arg-Gly-Asp-Ser. Keratocytes were grown on these templates in serum-free media for up to 90 days, and the resulting tissue was analysed for stromal-specific ECM markers at transcriptional and protein levels. Retinoic acid (RA) at 1×10-5 M was added to culture media during growth to inhibit MMP expression from keratocytes,2 and then removed to elicit PA template degradation and tissue self-release.

 
Results
 

We successfully fabricated human corneal tissue in vitro solely by culturing human donor-isolated keratocytes on a smart template (Fig. 1). This template promoted integrin-mediated adhesion, and keratocyte proliferation and stratification. The addition of RA to serum-free media further enhanced these effects, and significantly increased the production of keratocyte markers such as collagen type-I, keratocan, lumican, and ALDH1. Furthermore, RA reduced MMP activity from culture supernatant to less than 5% of control, thus ensuring the integrity of the PA template throughout the entire period in culture and allowing the formation of structurally coherent, ECM-enriched, robust corneal tissue. By resuming MMP expression after RA removal, we were able to control template degradation and promote tissue self-release, minimizing damage from manipulation.

 
Conclusions
 

This study demonstrates a feasible bottom-up strategy to create native-like bio-prosthetic corneal tissue entirely fabricated by human keratocytes in vitro. This has evident applications in regenerative medicine. 1. Gouveia et al., J Mater Chem B, 2013,1: 6157 2. Gouveia and Connon, Invest Ophthalmol Vis Sci, 2013, 54: 7483

  
Keywords: 484 cornea: stroma and keratocytes • 519 extracellular matrix • 575 keratoprostheses  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×